期刊文献+

奥氮平对首发精神分裂症患者的疗效及认知功能影响

Curative Effect of Olanzapine in Treating Patients with First-episode Schizophrenia and Its Impact on Cognition
下载PDF
导出
摘要 目的观察奥氮平对首发精神分裂症患者的疗效及认知功能的影响。方法将31例首发精神分裂症患者经奥氮平治疗前及治疗12周后,用阳性症状量表(SAPS)、阴性症状量表(SANS)、韦氏成人智力量表(WAIS-R)、韦氏记忆量表(WMS)、简明精神症状评定量表(BPRS)、韦斯康星卡片分类测验(WCST)进行评估,观察奥氮平对精神分裂症症状的改变及对认知功能的影响。结果治疗后阳性症状、阴性症状量表、简明精神症状评定量表、韦斯康星卡片分类测验中错误应答数的评估分值显著降低(P<0.01),韦斯康星卡片分类测验中的非持续性错误、韦氏记忆量表中的再生、理解评估分值明显降低(P<0.05)。结论奥氮平治疗精神分裂症疗效可靠并可显著改善部分患者的认知功能。 Objective To observe the curative effect of olanzapine in treating patients with first - episode schizophrenia and its im- pact on cognition. Methodss 31 patients with first - episode schizophrenia were treated with olanzapine for 12 weeks; before and after treatment, SAPS, SANS, WAIS- R, WMS, BPRS and WCST were applied for evaluation, and the effect of olanzapine on symptom improve- ment and cognition was observed. Results After treatment,the evaluation scores of false answers in SAPS,SANS,BPRS and WCST decreased obviously ( P 〈 0.01 ) as well as the evaluation scores of nonpersistent mistakes in WCST and the evaluation scores of reactivation and comprehension in WMS ( P 〈 0.05}. Conclusions Olanzapine is effective in treating patients with first - episode schizophrenia and it can obviously improve the cognition of some patients.
作者 沈秀梅
出处 《西南军医》 2008年第6期20-21,共2页 Journal of Military Surgeon in Southwest China
关键词 奥氮平 首发精神分裂症 疗效 认知功能 olanzapine first- episode schizophrenia curative effect cognition
  • 相关文献

参考文献8

二级参考文献39

  • 1[6]Charles M,Beasley J,Gary D,et al.Safety of olanzapine[J].J Clin Psychiatry,1997,581(Suppl 10):13
  • 2[1]Kopala LC, Fredrikson D, KP, et al. Symptoms in neurolepticnerve, first-episode schizophrenia: response to risperidone. Biol Psychiatry, 1998, 36: 296
  • 3[4]Lieberman JA, Mailman RB, Duncan G, et al. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol Psychiatry, 1998, 44: 1099~1117
  • 4[5]Bilder RM. Neurocognitive impairment in schizophrenia and how it affects treatment options. Can J Psychiatry, 1997, 42 : 255 ~264
  • 5[7]Azorin JM, Spiegel R, et al. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Am J Psychoatry, 2001 Aug, 158(8) : 1305
  • 6[8]Berier AF, Malhotra AK, et al. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinson side effects, and neuroendocrine respose. Am J Psychiatry, 2000 Feb, 157(2) : 310
  • 7[9]Heinrich K, Klieser E, Lehmann E, et al. Risperidone versus clozapin in treatment of schizophrenia patient with acute symptoms. Prog Neuropsychopharmacol Biol Psychiatry, 1994, 18 : 129
  • 8于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330
  • 9李华芳,顾牛范.新型抗精神病药:利培酮[J].上海精神医学,1997,9(1):47-50. 被引量:84
  • 10陈文 蓝光华 等.奥氮平临床应用14例观察小结[J].临床精神医学杂志,1999,9:318-318.

共引文献217

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部